Eric A. Appel

Check out the news coverage of @abigail_kate95 work on improving CAR-T therapy for solid tumors. Thanks @LouaiLabanieh and @MackallLab for this awesome collab! @StanfordMed @StanfordEng @StanfordMSE @StanfordCancer @StanfordPeds news.stanford.edu/?p=43259 via @Stanford

@mseatpenn is excited to welcome Eric Appel @AppelGroup, Stanford University, to discuss his work, “Dynamic Biomaterials Enabling Innovations in Cell and Drug Delivery” on Thursday, March 19, 2026, beginning at 10:30 AM - Wu and Chen Auditorium, Levine Hall.

Finally, someone has solved a real problem with AI! No more having to take a paper in the format for a journal that rejected you, and reformat it for a new journal. Well done!! formatmypaper.com

If you're at @BMESociety #BMES2025 this week, check out @AlexProssnitz at the meet the faculty candidates gathering!

Fwd: Fwd: “I hope this email finds you well”

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2025 #NobelPrize in Physics to John Clarke, Michel H. Devoret and John M. Martinis “for the discovery of macroscopic quantum mechanical tunnelling and energy quantisation in an electric circuit.”

📢 We’re hiring! @StanfordUChem is now accepting applications for a Junior Faculty Position in Chemistry (open area), with the appointment set to begin on September 1, 2026. Learn more and apply here: facultypositions.stanford.edu/cw/en-us/job/4… #FacultyJobs #AcademicJobs #Hiring

@Idoyaga_Lab @NatImmunol What an awesome image

Our paper made the September cover of @NatImmunol! 🎉 Aren’t dendritic cells beautiful? 😍 SEM shows pDCs transitioning into cDC2-like cells. Huge congrats to the whole team! 👏 🔗 nature.com/ni/volumes/26/…

The handedness of redwoods still blows my mind #chiral

Spray-dried microparticles with a stabilizing polymer excipient enable ultra-high protein concentration therapeutics for subcutaneous injection, and could expand home use of these critical pharmaceuticals. @AppelGroup @StanfordMSE scim.ag/4fNCO3H

Spray-dried microparticles with a stabilizing polymer excipient enable ultra-high protein concentration therapeutics for subcutaneous injection, and could expand home use of these critical pharmaceuticals. @ScienceTM scim.ag/4fNDgip

A beautiful sight

Shoshana conducted this really cool study developing a module for high school students (and potentially undergraduates) in on the chemistry of #henna that was published in the Journal of Chemical Education @ACSDivCHED: pubs.acs.org/doi/full/10.10…

Check out this highlight of Shoshana William's work on #henna by @Stanford_ChEMH @Stanford! chemh.stanford.edu/news/art-chemi…

Spray-dried microparticles with a stabilizing polymer excipient enable ultra-high protein concentration therapeutics for subcutaneous injection, and could expand home use of these critical pharmaceuticals. @AppelGroup @StanfordMSE scim.ag/4fNCO3H

Ultrahigh-concentration biologic therapeutics enabled by spray drying with a glassy surfactant excipient "The technology could open the door for home injection of many protein-based drugs that are only available in the clinic." science.org/doi/10.1126/sc…

IV Therapies Transformed into Injections with a Novel Spray Drying Platform A new delivery platform allows protein #therapeutics to be delivered in higher concentrations and injected with a standard syringe @AppelGroup @Stanford #drugdelivery #proteins hubs.li/Q03DTkcW0

Our ultra-high concentration biologic delivery work made the front page of the @ScienceMagazine website!

In this work we developed a spray-drying approach for protein therapeutics leveraging our polyacrylamide copolymer excipient we previously developed to stabilize proteins. This excipient technology was reported a few years ago in @ScienceTM: science.org/doi/10.1126/sc…

A copolymer excipient enables stable, ultrahigh-concentration protein formulations for subcutaneous injection @ScienceTM @AppelGroup @AlexProssnitz science.org/doi/10.1126/sc…